These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2340551)

  • 1. [Ofloxacin in the treatment of infections of the respiratory tract in older patients].
    Krcméry V; Cernák P; Cepcek P
    Cas Lek Cesk; 1990 Mar; 129(10):309-11. PubMed ID: 2340551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with parenteral and oral ofloxacin in severe infections.
    Kanellakopoulou K; Giamarellou H
    Scand J Infect Dis Suppl; 1990; 68():64-9. PubMed ID: 2218425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect and tolerance of ofloxacin in bronchopulmonary infections in comparison with amoxicillin].
    Chuard C; Regamey C
    Schweiz Med Wochenschr; 1989 Dec; 119(52):1913-6. PubMed ID: 2692153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of ofloxacin versus cefazolin in lower respiratory tract infections.
    Bariffi F; Giacomelli P; Sanduzzi A; Perna F; De Masi AL
    Int J Clin Pharmacol Res; 1987; 7(3):199-201. PubMed ID: 3474212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
    Stocks JM; Wallace RJ; Griffith DE; Garcia JG; Kohler RB
    Am J Med; 1989 Dec; 87(6C):52S-56S. PubMed ID: 2690620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of ofloxacin (Tarivid) therapy in respiratory and urinary tract infections].
    Hasçelik G
    Mikrobiyol Bul; 1987 Jul; 21(3):165-71. PubMed ID: 3332699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of Chinese ofloxacin].
    Hou SR
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):238-41, 255-6. PubMed ID: 8395321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of Visiren administration in patients with respiratory infections].
    Plavsić Z; Filipović M; Popovac D
    Srp Arh Celok Lek; 1990; 118(11-12):455-7. PubMed ID: 2133600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical safety and efficacy of ofloxacin.
    Marone P; Concia E; Grossi P; Malfitano A; Perversi L
    Chemioterapia; 1988 Oct; 7(5):320-2. PubMed ID: 3224401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
    Cantón R; Lode H; Graninger W; Milkovich G
    Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S115-27. PubMed ID: 16904873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation.
    Liam CK; Aziah AM; Lim KH; Wong CM
    Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
    Sollet JP
    Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S113-4. PubMed ID: 16904296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position of ceftazidime in respiratory diseases.
    Ando' F; Girbino G; Ferrara F
    Drugs Exp Clin Res; 1985; 11(6):369-72. PubMed ID: 3915288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fleroxacin versus ofloxacin in patients with complicated urinary tract infection: a controlled clinical study.
    Naber KG; Sigl G
    Am J Med; 1993 Mar; 94(3A):114S-117S. PubMed ID: 8452166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ofloxacin in the treatment of lower respiratory tract infections in patients with chronic pulmonary diseases].
    Marcos Sánchez F; Aparicio Martínez JC; Celdrán Gil J; Durán Pérez-Navarro A
    An Med Interna; 1992 Aug; 9(8):411-2. PubMed ID: 1391568
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of antibiotic prescription in acute respiratory infections in adults. The Spanish Study Group on Antibiotic Treatments.
    Ochoa C; Eiros JM; Inglada L; Vallano A; Guerra L
    J Infect; 2000 Jul; 41(1):73-83. PubMed ID: 10942644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B; Wilen-Rosenqvist G; Lehtonen L
    Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacovigilance study of azithromycin tablets (500 mg) in the treatment of adult patients with respiratory tract infections].
    Alvarez MP; Simón M; Sánchez S; Apaloaza I; Prieto J
    Rev Esp Quimioter; 2000 Sep; 13(3):297-305. PubMed ID: 11086281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of ofloxacin in the treatment of bacterial infections of the respiratory tract].
    Musiał J; Sładek K; Kotlinowska T; Szczeklik A
    Pol Tyg Lek; 1988 Dec; 43(49):1580-2. PubMed ID: 3076652
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
    Peng MY
    J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.